2028년까지 유럽 뇌암 진단 시장 예측 – 진단 유형(영상 검사, 요추 천자, 생검, 분자 검사 등)별 코로나19 영향 및 지역 분석; 암 유형(청각신경종, 성상세포종, 두개인두종, 신경절신경종, 다형성 교모세포종, 수막종, 뇌막세포종 및 기타); 최종 사용자(병원, 전문 진료소, 외래 수술 센터 등)

시장 소개

뇌암은 종양을 유발하는 뇌 세포의 세포외 성장으로 인해 발생합니다. 종양에는 원발성 뇌종양과 이차성 뇌종양이 있습니다. 원발성 뇌종양은 뇌에서 형성되며 신체의 다른 부위로 퍼지지 않는 반면, 전이라고도 알려진 이차 종양은 신체의 다른 부위에서 시작된 암입니다. 뇌종양은 40가지 주요 유형으로 분류되며, 더 나아가 성장 속도가 느리고 전이 가능성이 낮은 양성 유형과 암성이며 전이 가능성이 높은 악성 유형의 두 가지 주요 그룹으로 더 분류됩니다.

< p>따라서 뇌암 유병률의 증가는 향후 뇌암 진단에 대한 상당한 수요를 창출할 것으로 예상되며, 이는 뇌암 진단 시장을 더욱 주도할 것으로 예상됩니다.

암 환자는 코로나19 팬데믹 기간 동안 부정적인 영향을 받은 사람들이 많습니다. 이들 중 다수는 면역이 억제되어 있고 나이가 많을 수 있기 때문입니다. 또한 전 세계 많은 진료소에서 암 추적 관찰이나 영상 촬영 예약이 지연되고 있습니다. 정기 검진을 연기하면 새로운 암 진단도 늦어진다. 클리닉은 지역적 코로나19 발생에 따라 예약 일정을 지속적으로 모니터링하고 조정하고 있습니다. 암 환자를 대상으로 한 코로나19에 대한 연구는 제한적이지만, 이 인구 집단이 더 심각한 코로나19 질환에 걸릴 위험이 있다는 점은 일관되게 나타납니다. 최근 연구 데이터에 따르면 소아 암 환자는 성인에 비해 중증 코로나19 질환에 걸릴 위험이 더 낮습니다. 폐, 뇌, 위장 영상을 통해 감지된 SARS-CoV-2 감염의 특정 특징은 방사선 전문의를 혼란스럽게 할 수 있습니다. 암 진단, 병기 결정 및 치료 반응의 해석. 마지막으로, 진료소가 정기 진료를 위해 다시 문을 열면서 환자 방문 중 SARS-CoV-2 노출을 줄이기 위한 프로토콜이 마련되었습니다. 이 검토에서는 코로나19 팬데믹이 암 환자와 암 영상 촬영에 미치는 영향에 대한 다양한 관점을 자세히 설명합니다.

시장 개요 및 역학

유럽의 뇌암 진단 시장은 2021년 2억 750만 달러에서 601.0달러로 성장할 것으로 예상됩니다. 2028년까지 백만 달러; 2021년부터 2028년까지 CAGR 16.4%로 성장할 것으로 예상됩니다. 인공 지능은 일반적으로 인간 지능과 관련된 작업을 수행하기 위해 강력한 컴퓨터를 사용하는 것을 포함합니다. 딥 러닝이라고 불리는 일종의 인공 지능은 복잡한 수학적 알고리즘(컨볼루션 신경망이라고도 함)을 사용하여 데이터에서 특징을 추출한 다음 이를 \"훈련\"합니다. 이러한 훈련을 통해 알고리즘은 패턴을 인식하고 이미지 분석과 같은 작업을 수행할 수 있습니다. 연구진은 SRH 이미저의 강력한 기능을 AI와 결합하기 위해 SRH가 생성한 뇌종양 조직 이미지에 대한 알고리즘 트레이닝을 수행하기 시작했습니다. 연구진은 인공지능 기술과 병리학자가 서로를 검증할 수 있는 능력은 병리학자가 인공지능 기술과 협력하여 어려운 사례를 해석하고 가능한 최고의 진단 정확도를 보장해야 할 필요성을 강조한다고 지적했습니다. SRH와 AI 이미징은 모두 새로운 기술이므로 의료에 통합하는 것이 어려울 것입니다. AI 기술을 통해 외과의사는 종양이나 건강한 조직이 포함된 부위를 빠르고 정확하게 식별할 수 있습니다. 따라서 수술 중 뇌종양 진단을 향상시키기 위해 SRH 인공 지능이 점점 더 많이 사용되고 있습니다.

주요 시장 부문

진단 유형 측면에서, 영상 테스트 부문은 2020년 유럽 뇌암 진단 시장에서 가장 큰 점유율을 차지했습니다. 암 유형 측면에서 다형성 교모세포종 부문은 2020년 유럽 뇌암 진단 시장에서 가장 큰 점유율을 차지했습니다. 최종 사용자 측면에서는 병원 부문은 2020년 유럽 뇌암 진단 시장에서 가장 큰 점유율을 차지했습니다.

주요 소스 및 회사 목록

유럽의 뇌암 진단 시장에 대한 이 보고서를 준비하기 위해 참조된 몇 가지 주요 1차 및 2차 소스는 연간 회사 웹사이트입니다. 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사로는 Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, Biocept, Inc., Koninklijke Philips NV, Canon Medical Systems, Hitachi, Ltd. 및 Neusoft Medical Systems가 있습니다.

이유 보고서 구매

유럽 뇌암 진단 시장 환경을 이해하고 강력한 성장을 보장할 가능성이 가장 높은 시장 부문을 식별합니다. return
유럽 뇌암 진단 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가십시오.
다음을 식별하여 유럽 뇌암 진단 시장에서 M&A 및 파트너십 거래를 효율적으로 계획하십시오. 가장 유망한 판매 가능성이 있는 시장 부문
유럽 뇌암 진단 시장의 다양한 부문의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내리는 데 도움이 됩니다.
시장 수익 예측 획득 2021~2028년 유럽 지역의 다양한 부문별 시장.

유럽 뇌암 진단 시장 세분화

진단 유형별

영상 테스트
- MRI
- CT 스캔
- PET
생검
분자 검사
요추 천자
기타

암 유형별

다형성 교모세포종
성상세포종
상세포종
기타

작성자최종 사용자

병원
전문 진료소
외래 수술 센터
기타

국가별

유럽
- 독일
- 영국
- 프랑스
- 스페인
- 이탈리아
- 유럽 나머지 지역

< Strong>언급된 회사

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2 Brain Cancer Diagnostics Market – By Cancer Type

1.3.3 Brain Cancer Diagnostics Market – By End User

1.3.4 Europe Brain Cancer Diagnostics Market – By Country

2. Europe Brain Cancer Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Brain Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Brain Cancer Diagnostics Market- Europe PEST Analysis

4.3 Expert Opinion

5. Europe Brain Cancer Diagnostics Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Brain Cancer

5.1.2 Rise in Number of Cigarette Smokers

5.2 Market Restraints

5.2.1 High Cost of Diagnosis

5.3 Future Trends

5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4 Impact Analysis

6. Brain Cancer Diagnostics Market – Europe Analysis

6.1 Europe Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7. Europe Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1 Overview

7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3 Imaging Tests

7.3.1 Overview

7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 MRI

7.3.3.1 Overview

7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 CT Scan

7.3.4.1 Overview

7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Positron emission tomography (PET)

7.3.5.1 Overview

7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Lumbar Puncture

7.4.1 Overview

7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Biopsy

7.5.1 Overview

7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Molecular Testing

7.6.1 Overview

7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1 Overview

8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3 Astrocytomas

8.3.1 Overview

8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Glioblastoma Multiforme

8.4.1 Overview

8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Ependymomas

8.5.1 Overview

8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Brain Cancer Diagnostics Market Analysis – By End user

9.1 Overview

9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Specialty Clinics

9.4.1 Overview

9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 Europe: Brain Cancer Diagnostics Market Revenue and Forecasts to 2028

10.1.1 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

10.1.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.2.2.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.2.3 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.2.4 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.3 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.3.1 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.3.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.3.2.1 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.3.3 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.3.4 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.4 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.4.1 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.4.2 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.4.2.1 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.4.3 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.4.4 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.5 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.5.1 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.5.2 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.5.2.1 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.5.3 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.5.4 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.6 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.1 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.2 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.6.2.1 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.6.3 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.6.4 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.7 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.7.1 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.7.2 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.7.2.1 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.7.3 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.7.4 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on Europe Brain Cancer Diagnostics Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.1 Organic Developments

12.1.1 Overview

12.2 Inorganic Developments

12.2.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Siemens Healthineers AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GE Healthcare

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Biocept, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Koninklijke Philips N.V.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Canon Medical Systems

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Hitachi, Ltd.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Neusoft Medical Systems

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type US$ Mn)

Table 2. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test US$ Mn)

Table 3. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 4. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 5. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 6. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 7. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 8. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 9. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 10. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 11. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 12. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 13. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 14. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 15. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 16. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 17. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 18. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 19. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by Cancer Type (USD Million)

Table 20. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by End User (USD Million)

Table 21. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 22. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 23. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 24. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 25. Organic Developments in the Brain Cancer Diagnostics Market

Table 26. Inorganic Developments in the Brain Cancer Diagnostics Market

Table 27. Glossary of Terms, Brain Cancer Diagnostics Market

LIST OF FIGURES

Figure 1. Brain Cancer Diagnostics Market Segmentation

Figure 2. Europe Brain Cancer Diagnostics Market Overview

Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4. Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Brain Cancer Diagnostics Market - Europe PEST Analysis

Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7. Europe Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Europe: Brain Cancer Diagnostics Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 28. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

Figure 29. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. Germany Brain Cancer Diagnostics Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 35. Impact of COVID-19 Pandemic in European Country Markets

Figure 36. Growth Strategies Done by the Companies in the Market, (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe brain cancer diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample